ANIX logo

Anixa Biosciences (ANIX) Company Overview

Profile

Full Name:

Anixa Biosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 7, 1983

Indexes:

Not included

Description:

Anixa Biosciences is a biotechnology company focused on developing innovative therapies and diagnostics for cancer and infectious diseases. They aim to improve patient outcomes through advanced research and technology, including immunotherapy and vaccine development. Their work targets both prevention and treatment of serious health conditions.

Events Calendar

Earnings

Next earnings date:

Mar 12, 2025

Recent quarterly earnings:

Jun 4, 2024

Recent annual earnings:

Jan 7, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 18, 2016

Analyst ratings

Recent major analysts updates

Feb 18, 25 HC Wainwright & Co.
Buy
Jan 22, 25 D. Boral Capital
Buy
Jan 14, 25 D. Boral Capital
Buy
Nov 19, 24 HC Wainwright & Co.
Buy
Nov 19, 24 D. Boral Capital
Buy
Nov 11, 24 D. Boral Capital
Buy
Sep 30, 24 EF Hutton
Buy
Sep 24, 24 EF Hutton
Buy
Sep 17, 24 HC Wainwright & Co.
Buy
Sep 9, 24 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Anixa Biosciences?
  • Does Anixa Biosciences pay dividends?
  • What sector is Anixa Biosciences in?
  • What industry is Anixa Biosciences in?
  • What country is Anixa Biosciences based in?
  • When did Anixa Biosciences go public?
  • Is Anixa Biosciences in the S&P 500?
  • Is Anixa Biosciences in the NASDAQ 100?
  • Is Anixa Biosciences in the Dow Jones?
  • When was Anixa Biosciences's last earnings report?
  • When does Anixa Biosciences report earnings?
  • Should I buy Anixa Biosciences stock now?

What is the ticker symbol for Anixa Biosciences?

The ticker symbol for Anixa Biosciences is NASDAQ:ANIX

Does Anixa Biosciences pay dividends?

No, Anixa Biosciences does not pay dividends

What sector is Anixa Biosciences in?

Anixa Biosciences is in the Healthcare sector

What industry is Anixa Biosciences in?

Anixa Biosciences is in the Biotechnology industry

What country is Anixa Biosciences based in?

Anixa Biosciences is headquartered in United States

When did Anixa Biosciences go public?

Anixa Biosciences's initial public offering (IPO) was on October 7, 1983

Is Anixa Biosciences in the S&P 500?

No, Anixa Biosciences is not included in the S&P 500 index

Is Anixa Biosciences in the NASDAQ 100?

No, Anixa Biosciences is not included in the NASDAQ 100 index

Is Anixa Biosciences in the Dow Jones?

No, Anixa Biosciences is not included in the Dow Jones index

When was Anixa Biosciences's last earnings report?

Anixa Biosciences's most recent earnings report was on Jun 4, 2024

When does Anixa Biosciences report earnings?

The next expected earnings date for Anixa Biosciences is Mar 12, 2025

Should I buy Anixa Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions